You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 12, September 22/29, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Radiologic Imaging
 •Renal Diseases
 •Renal Diseases, Other
 •Radiography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We found some of the results in the study by Dr Merten and colleagues1 surprising. The change in serum creatinine level after radiographic contrast (mean difference, 0.11 mg/dL; 95% confidence interval [CI], –1.10 to 0.30) was not significant while the change in estimated glomerular filtration rate (GFR) (mean difference, –8.6%; 95% CI, –17.0 to –0.2) was significant. Since in using the Levey formula, serum creatinine is the major determinant in calculating GFR, one might expect the change in creatinine and GFR to be of similar magnitude. We wonder if changes other than in creatinine could explain the calculated GFR change. The Levey formula uses age and sex, which would not change over 2 days, but also uses blood urea nitrogen (BUN) and serum albumin levels. While these values are stable over the long-term, it is possible that the infusion of sodium bicarbonate (NaHCO3) expanded extracellular fluid . . . [Full Text of this Article]

L. Shavit, MD
itz@szmc.org.il

M. Lifschitz, MD; J. Plaksin, MD; I. N. Slotki, MD
Division of Nephrology
Shaare Zedek Medical Center
Jerusalem, Israel



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate
Robert E. Siegel
JAMA. 2004;292(12):1428.
EXTRACT | FULL TEXT  

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate—Reply
W. Patrick Burgess, Gregory J. Merten, and Thomas P. Kennedy
JAMA. 2004;292(12):1428-1429.
EXTRACT | FULL TEXT  

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate: A Randomized Controlled Trial
Gregory J. Merten, W. Patrick Burgess, Lee V. Gray, Jeremiah H. Holleman, Timothy S. Roush, Glen J. Kowalchuk, Robert M. Bersin, Arl Van Moore, Charles A. Simonton, III, Robert A. Rittase, H. James Norton, and Thomas P. Kennedy
JAMA. 2004;291(19):2328-2334.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.